|1.||Wolin, Michael S: 3 articles (08/2013 - 06/2006)|
|2.||Varshney, R: 3 articles (05/2005 - 12/2003)|
|3.||Gupte, Sachin A: 2 articles (08/2006 - 06/2006)|
|4.||Dwarakanath, B S: 2 articles (12/2004 - 12/2003)|
|5.||Chandra, Partha K: 1 article (01/2015)|
|6.||Ferraris, Pauline: 1 article (01/2015)|
|7.||Reiss, Krzysztof: 1 article (01/2015)|
|8.||Kurt, Ramazan: 1 article (01/2015)|
|9.||Aboulnasr, Fatma: 1 article (01/2015)|
|10.||Balart, Luis A: 1 article (01/2015)|
09/15/1997 - "Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro."
02/23/1996 - "The effect of 6-aminonicotinamide on the metabolism of RIF-1 tumor cells was investigated using 13C and 31P NMR spectroscopy. "
02/23/1996 - "13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro."
01/01/1964 - "AUGMENTATION OF 6-AMINONICOTINAMIDE ANTAGONISM OF TUMOR GROWTH BY COMPOUNDS WITH ESTROGENIC ACTIVITY."
01/01/1963 - "FORMATION OF GLYCOLYTIC INHIBITOR FROM 6-AMINONICOTINAMIDE BY ASCITES TUMOR CELLS IN VIVO AND IN VITRO, AND METABOLIC REQUIREMENTS FOR FORMATION OF THIS INHIBITOR."
04/01/1996 - "An immunohistochemical study of the intraventricular macrophages in induced hydrocephalus in prenatal rats following a maternal injection of 6-aminonicotinamide."
02/01/2014 - "Spontaneous subdural blood collections were found after creation of hydrocephalus in mice by systemic injection of the neurotoxin, 6-aminonicotinamide. "
06/01/1996 - "Morphological and developmental changes of the ventricular system are analyzed in three major experimental models of congenital hydrocephalus in the rat: 6-aminonicotinamide (6-AN)-induced and LEW/Jms and HTX mutant hydrocephalus. "
04/01/1996 - "Hydrocephalus was induced experimentally in prenatal rats following an injection of 6-aminonicotinamide (6-AN) into pregnant rats. "
11/01/1970 - "Early neurovascular abnormalities underlying 6-aminonicotinamide (6-AN)-induced congenital hydrocephalus in rats."
|3.||Cleft Palate (Palate, Cleft)
04/01/1979 - "Correlation between mandibular retrognathia and induction of cleft palate with 6-aminonicotinamide in the rat."
04/12/1968 - "The frequency of congenital cleft palate produced by maternal treatment with 6-aminonicotinamide during pregnancy is lower in the C57BL/6J than in the A/J inbred mouse strain. "
09/01/1966 - "Development of cleft palate induced by 6-aminonicotinamide late in rat gestation."
03/01/1988 - "In a search for genetic differences in susceptibility to cleft palate, congenic and recombinant inbred strains of mice were treated with 6-aminonicotinamide or control injections. "
03/18/2005 - "Correlation of susceptibility to 6-aminonicotinamide and hydrocortisone-induced cleft palate."
|4.||Cleft Lip (Harelip)
08/01/1983 - "A search was made for cell ultrastructure differences in the initial fusion process of the medial and lateral nasal processes in mouse embryos of the following types: A/J with 12% cleft lip (CL), CL/Fr with 23% CL--both cleft-lip-predisposed strains, CL/Fr 6-aminonicotinamide (6AN)-treated (94% CL) and controls from the C57BL/6 strain (0% CL) and dancer stock (0% CL). "
04/01/1982 - "C57BL/6 embryos observed near term following treatment with 6-aminonicotinamide (6AN) at gestation D9/12 (vp day = day 0) had 18% median cleft lip. "
08/01/1976 - "The lines had been selected from one original population using frequency of cleft lip induced by 6-aminonicotinamide as the selection criterion. "
03/18/2005 - "Our previous genome-wide Quantitative Trait Locus (QTL) mapping study using mouse A/J by C57BL/6J recombinant inbred (RI) lines suggested several chromosomal regions contain genes influencing susceptibility to phenytoin (PT)-induced cleft lip with or without cleft palate [CL(P)] and 6-aminonicotinamide (6-AN)-induced isolated cleft palate (CP). "
05/13/1997 - "We compare results obtained using phenytoin (which induces cleft lip) and 6-aminonicotinamide (which induces cleft palate). "
10/01/1986 - "A collaborative study was conducted to investigate the teratological susceptibility of the Pika (Ochotona rufescens rufescens) to selected teratogenic chemicals: cyclophosphamide, 6-mercaptopurine, 5-fluorouracil, 6-aminonicotinamide, actinomycin D, ethylurethan, ampicillin, tetracycline, thalidomide, diphenylhydantoin, hypervitaminosis A, aspirin, dexamethasone, betamethasone and bredinin. "
|2.||NSC 224131 (PALA)
|4.||Transplantation (Transplant Recipients)